Ontruzant Injection, Powder, Lyophilized, For Solution
Product Images NDC 78206-147

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ontruzant (NDC 78206-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ont02 0000 01)

FDA Label Image

Figure 2 (Ont02 0000 02)

FDA Label Image

Figure 3 (Ont02 0000 03)

FDA Label Image

Figure 4 (Ont02 0000 04)

FDA Label Image

Figure 5 (Ont02 0000 05)

FDA Label Image

Figure 6 (Ont02 0000 06)

FDA Label Image

Figure 7 (Ont02 0000 07)

FDA Label Image

Samsung Bioepis Logo (Ont02 0000 08)

FDA Label Image

Merck Logo (Ont02 0000 09)

FDA Label Image

Principal Display Panel (Ontruzant Carton Label)

FDA Label Image

Principal Display Panel – Kit Label (Ont02 0000 11)

This text appears to be a mixture of technical information related to a medical product called Ontruzant, including dosage, storage requirements, and reconstitution instructions. The text also contains information about the manufacturer and distribution of the product. There is also a reference to a potential trademark associated with the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.